STATE STREET CORP

Position in RPRX — Royalty Pharma plc

CIK 93751 BOSTON, MA

Back to RPRX Full portfolio

Position in RPRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$527,183,152

+$115,681,024 QoQ

Shares Held

10,989,851

+3.2% QoQ

Ownership

1.91%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

24 quarters on record

Voting authority Sole 30% Shared 2% None 68%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. RPRX ranks #7 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,730,139	$5,237,976,269
2	REGN	Regeneron Pharmaceuticals, Inc.	4,664,478	$3,603,962,281
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,322,698	$1,099,381,087
4	INSM	INSMED Inc	5,551,699	$907,813,820
5	INCY	Incyte Corp	9,641,384	$907,447,062
6	MRNA	Moderna, Inc.	14,861,409	$754,959,577
7	RPRX	Royalty Pharma plc This page	10,989,851	$527,183,152
8	ROIV	Roivant Sciences Ltd.	16,186,613	$448,369,180

All Filings in RPRX

Export CSV

24 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$527,183,152	10,989,851	+3.2%	Shares	Defined	2026-05-15
2025-12-31	$411,502,128	10,649,641	+3.7%	Shares	Defined	2026-02-13
2025-09-30	$362,422,725	10,272,753	+0.8%	Shares	Defined	2025-11-14
2025-06-30	$367,323,616	10,194,938	+7.1%	Shares	Defined	2025-08-14
2025-03-31	$296,237,064	9,516,128	-2.5%	Shares	Defined	2025-05-15
2024-12-31	$248,981,758	9,760,163	+2.6%	Shares	Defined	2025-02-14
2024-09-30	$269,215,051	9,516,262	+0.3%	Shares	Defined	2024-11-14
2024-06-30	$250,167,206	9,486,811	+4.2%	Shares	Defined	2024-08-14
2024-03-31	$276,371,494	9,100,148	+2.6%	Shares	Defined	2024-05-15
2023-12-31	$249,258,019	8,873,550	+5.3%	Shares	Defined	2024-02-14
2023-09-30	$228,671,218	8,425,616	+2.9%	Shares	Defined	2023-11-14
2023-06-30	$251,663,400	8,186,838	-1.8%	Shares	Defined	2023-08-14
2023-03-31	$300,519,204	8,340,805	+2.7%	Shares	Defined	2023-05-15
2022-12-31	$320,897,736	8,119,882	+2.5%	Shares	Defined	2023-05-15
2022-09-30	$318,282,454	7,921,415	+3.6%	Shares	Defined	2022-11-15
2022-06-30	$321,384,869	7,644,740	-1.5%	Shares	Defined	2022-08-15
2022-03-31	$302,429,805	7,762,572	+9.7%	Shares	Defined	2022-05-16
2021-12-31	$282,031,600	7,077,330	+21.3%	Shares	Defined	2022-02-14
2021-09-30	$210,867,684	5,834,745	+19.9%	Shares	Defined	2021-11-15
2021-06-30	$199,524,317	4,867,634	+3.9%	Shares	Defined	2021-08-16
2021-03-31	$204,397,344	4,685,863	+98.7%	Shares	Defined	2021-07-09
2020-12-31	$118,004,987	2,357,742	+131.6%	Shares	Defined	2021-02-16
2020-09-30	$42,835,421	1,018,194	+2395.6%	Shares	Defined	2020-11-10
2020-06-30	$1,980,840	40,800	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.